Scientists test new Long-Lasting schizophrenia shots
NCT ID NCT06319170
Summary
This study aimed to understand how three new long-acting injection formulas of the drug olanzapine are absorbed by the body. It involved 106 adults with schizophrenia or schizoaffective disorder. Researchers compared how long the drug stayed in the bloodstream and monitored for side effects over 19 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 15726
Marlton, New Jersey, 08053, United States
-
Teva Investigational Site 15727
Hollywood, Florida, 33024, United States
-
Teva Investigational Site 15728
Decatur, Georgia, 30030, United States
-
Teva Investigational Site 15729
Atlanta, Georgia, 30331, United States
-
Teva Investigational Site 15730
Los Alamitos, California, 90720, United States
Conditions
Explore the condition pages connected to this study.